Show
Sort by
-
A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil : final analysis of the Complement 1 phase 3 trial
-
- Journal Article
- A1
- open access
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia : results from the pivotal phase III study COMPLEMENT1
-
Long-term follow-up of previously untreated patients (pts) with chronic lymphocytic leukemia (CLL) treated with ofatumumab (OFA) and chlorambucil (CHL) : final analysis of the phase 3 COMPLEMENT 1 trial.
-
Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLL
-
A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL
-
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial
-
Results from the international, randomized phase 3 study of ibrutinib versus chlorambucil in patients 65 years and older with treatment-naive CLL/SLL (RESONATE-2 (TM))
-
Gene mutations and treatment outcome in CLL patients treated with chlorambucil (Chl) or ofatumumab-Chl (O-Chl): results from the phase III study COMPLEMENT1 (OMB110911)
-
In vitro apoptosis and clonal evolution in chronic lymphocytic leukemia : predictive value and possible influence on treatment
(2013) -
Ofatumumab plus chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukemia (CLL): results of the phase III study complement 1 (OMB110911)
-
NOTCH1 mutation and treatment outcome in CLL patients treated with chlorambucil (Chl) or ofatumumab-chi (O-Chl): results from the phase III study complement 1 (OMB110911)
-
SAR245409 Monotherapy in relapsed/refractory follicular lymphoma: preliminary results from the phase II ARD12130 study
-
High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature
-
Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia
-
Methylprednisolone downregulates ZAP-70 expression in B-CLL cells in vitro
-
Prognostic significance of lipoprotein lipase expression in B-cell chronic lymphocytic leukemia
-
Kolmogorov-Smirnov statistical test for analysis of ZAP-70 expression in B-CLL, compared with quantitative PCR and IgVH mutation status
-
Prognostische factoren bij B-CLL
-
VH-gene usage is of prognostic value in CLL
-
CXCL-12 induces prolonged erk-phosphorylation in Zap-70 positive B-CLL
-
Correlation of ZAP-70 analysed by flow cytometry with IgVH mutational status in B-CLL
-
The restricted V-H-gene usage is of prognostic value in B-cell chronic lymphocytic leukemia
-
Cytotoxicity of gamma versus alpha radiation in lymphoid cell lines with defects in the TNF receptor family mediated and NF-kappa B related apoptotic and anti-apoptotic pathways
-
Alpha-immunotherapy compared to gamma-radiation, cold antibody, and chemotherapy in B-CLL in vitro: Correlation with clinical chemosensitivity
-
Essentiële thrombocytose.
-
Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia.
-
Comparison of in vitro apoptosis induction by alpha-irradiation versus gamma-irradiation in B-CLL
-
Bone marrow necrosis.
-
Non-Hodgkin's lymphoma presenting with spinal involvement.
-
Pyoderma gangrenosum as an early revelator of acute leukemia.
-
Chromosome 7 short arm deletions and disease progression in CML
-
Erythromelalgia: A clue to the diagnosis of polycythemia vera.